Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Mar 1;183(3):751-7.
doi: 10.1084/jem.183.3.751.

Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant

Affiliations
Comparative Study

Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant

J C Guéry et al. J Exp Med. .

Abstract

We have analyzed the relative contribution of dendritic cells (DC) and B cells in the presentation of peptide-class II complexes in an inflammatory situation in vivo. Draining lymph node cells from mice immunized subcutaneously with hen egg-white lysozyme (HEL) in adjuvant display HEL peptide-major histocompatibility complex class II complexes able to stimulate, in the absence of any further antigen addition, specific T hybridoma cells. The antigen-presenting capacity of three different antigen-presenting cell (APC) populations recruited in lymph nodes, DC (N418+, class II+, B220-, low buoyant density), large B cells (B220+, low buoyant density), and small B cells (B220+, high buoyant density), was analyzed. After immunization with HEL in adjuvant, DC are the only lymph node APC population expressing detectable HEL peptide-class II complexes. These results indicate that lymph node DC and not B cells are the APC initiating the immune response in vivo after administration of antigen in adjuvant.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Immunol. 1981 Dec;11(12):964-8 - PubMed
    1. J Exp Med. 1996 Feb 1;183(2):485-97 - PubMed
    1. J Immunol. 1987 May 1;138(9):2848-56 - PubMed
    1. J Immunol. 1988 Jun 1;140(11):3773-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5181-5 - PubMed

Publication types

MeSH terms

Substances